ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1578

Functional Screening of Micrornas Using the Inhibitor Library Identified Micrornas to Regulate Expression of MMP-3 and IL-6 in Rheumatoid Arthritis Synovial Fibroblasts

Fumitaka Mizoguchi, Hisanori Hasegawa and Hitoshi Kohsaka, Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: fibroblasts and rheumatoid arthritis (RA), MicroRNA

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Synovial fibroblasts play crucial roles in the pathogenesis of rheumatoid arthritis (RA). They secrete proteinases and proinflammatory cytokines to damage the synovial tissues in the RA joints. Their functions are regulated by a number of molecules including microRNAs (miRNAs). MiRNAs are endogenous small noncoding RNAs, and suppress expression of target genes by binding to 3’- untranslated region (UTR) of the corresponding messenger RNAs. The present study was conducted to identify miRNAs to regulate expression of matrix metalloproteinase-3 (MMP-3) and interleukin-6 (IL-6), which are crucial in the pathogenesis of RA.

Methods: Nine hundred and twenty-four inhibitors of human miRNAs were transfected individually into synovial fibroblast cell lines developed from the RA synovial tissues. The transfected cells were cultured in the presence or absence of 1 ng/ml TNF-α for 24-72 hours. The expression levels of MMP-3 and IL-6 were quantified with enzyme-linked immunosorbent assay. The expression level of ets variant 6 (ETV6) was determined with Western blotting and quantitative polymerase chain reaction analysis. MiRNA array analysis was conducted for evaluation of the miRNA expression levels in the synovial fibroblasts with or without the TNF-α stimulation.

Results: Functional screening of 924 miRNAs using miRNA inhibitor library identified 14 miRNAs to regulate expression of MMP-3 in synovial fibroblasts. Out of these miRNAs, miR-103, miR-129-5p, miR-135a and miR-193b have seed sequence that match with 3’ UTR of ETV6, which is a transcriptional repressor of MMP-3. The effects of the four miRNA inhibitors on MMP-3 expression were validated with independent experiments. Inhibitors of miR-103 and miR-129-5p suppressed the expression level of IL-6. The four miRNA inhibitors increased the protein expression of ETV6 without upregulating the mRNA level. MiRNA array analysis revealed that the expression levels of miR-103, miR-129-5p and miR-135a in synovial fibroblasts were increased when they were stimulated with TNF-α.

Conclusion: Functional screening of miRNAs using the inhibitor library identified miR-103, miR-129-5p, miR-135a and miR-193b, which target ETV6, as regulators of MMP-3 and IL-6 expression in RA synovial fibroblasts. These miRNAs could be novel drug targets in RA.


Disclosure: F. Mizoguchi, None; H. Hasegawa, None; H. Kohsaka, None.

To cite this abstract in AMA style:

Mizoguchi F, Hasegawa H, Kohsaka H. Functional Screening of Micrornas Using the Inhibitor Library Identified Micrornas to Regulate Expression of MMP-3 and IL-6 in Rheumatoid Arthritis Synovial Fibroblasts [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/functional-screening-of-micrornas-using-the-inhibitor-library-identified-micrornas-to-regulate-expression-of-mmp-3-and-il-6-in-rheumatoid-arthritis-synovial-fibroblasts/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/functional-screening-of-micrornas-using-the-inhibitor-library-identified-micrornas-to-regulate-expression-of-mmp-3-and-il-6-in-rheumatoid-arthritis-synovial-fibroblasts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology